Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty

Objective:Longitudinal data regarding random luteinizing hormone (LH) concentrations in patients with idiopathic central precocious puberty (ICPP) during treatment are limited. Therefore, we sought to evaluate random LH and estradiol concentrations during monthly leuprolide injection and their assoc...

Full description

Bibliographic Details
Main Authors: Pattara Wiromrat, Ouyporn Panamonta
Format: Article
Language:English
Published: Galenos Yayincilik 2019-09-01
Series:JCRPE
Subjects:
Online Access: http://www.jcrpe.org/archives/archive-detail/article-preview/elevated-random-luteinizing-hormone-is-an-unreliab/21134
_version_ 1797924156177645568
author Pattara Wiromrat
Ouyporn Panamonta
author_facet Pattara Wiromrat
Ouyporn Panamonta
author_sort Pattara Wiromrat
collection DOAJ
description Objective:Longitudinal data regarding random luteinizing hormone (LH) concentrations in patients with idiopathic central precocious puberty (ICPP) during treatment are limited. Therefore, we sought to evaluate random LH and estradiol concentrations during monthly leuprolide injection and their associations with pubertal progression and final adult height (FAH) in girls with ICPP.Methods:Medical records of 27 girls with ICPP who had attained FAH were reviewed. Patients’ height, weight, Tanner stage, growth rate (GR), bone age, random LH measured by both immunoradiometric and immunochemiluminescent methods, follicular-stimulating hormone (FSH) and estradiol levels were monitored until FAH.Results:Treatment was started at a mean (±standard deviation) age of 8.1±0.6 years with mean duration of 3.9±0.2 years. At six months of follow-up, random LH (p=0.048), FSH (p<0.001) and estradiol (p=0.023) concentrations were decreased compared with baseline. Thereafter, random LHs were well suppressed. GRs gradually decreased to prepubertal norm by month 12. Seventeen patients (63%) exhibited pubertal LH concentrations at least once during treatment visits. Furthermore, 43 of a total 116 (37%) LH measurements were found elevated. However, those patients with elevated random LH did not show signs of pubertal progression. After treatment, mean FAH was greater than predicted adult height (p<0.0001) and target height (p=0.03). At no time points of treatment did random LH, FSH and estradiol correlate with GRs or FAH.Conclusion:Elevated random LH is commonly found in ICPP girls during monthly leuprolide treatment. However, these elevations were not associated with clinical progression of puberty or decreased FAH, suggesting that it is not a reliable method for CPP monitoring.
first_indexed 2024-04-10T14:57:52Z
format Article
id doaj.art-9fc1f70a8fbf46b7803944dab70a52e5
institution Directory Open Access Journal
issn 1308-5727
1308-5735
language English
last_indexed 2024-04-10T14:57:52Z
publishDate 2019-09-01
publisher Galenos Yayincilik
record_format Article
series JCRPE
spelling doaj.art-9fc1f70a8fbf46b7803944dab70a52e52023-02-15T16:07:17ZengGalenos YayincilikJCRPE1308-57271308-57352019-09-0111322723310.4274/jcrpe.galenos.2018.2018.021313049054Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious PubertyPattara Wiromrat0Ouyporn Panamonta1 Khon Kaen University Faculty of Medicine, Department of Pediatrics, Division of Endocrinology, Khon Kaen, Thailand Khon Kaen University Faculty of Medicine, Department of Pediatrics, Division of Endocrinology, Khon Kaen, Thailand Objective:Longitudinal data regarding random luteinizing hormone (LH) concentrations in patients with idiopathic central precocious puberty (ICPP) during treatment are limited. Therefore, we sought to evaluate random LH and estradiol concentrations during monthly leuprolide injection and their associations with pubertal progression and final adult height (FAH) in girls with ICPP.Methods:Medical records of 27 girls with ICPP who had attained FAH were reviewed. Patients’ height, weight, Tanner stage, growth rate (GR), bone age, random LH measured by both immunoradiometric and immunochemiluminescent methods, follicular-stimulating hormone (FSH) and estradiol levels were monitored until FAH.Results:Treatment was started at a mean (±standard deviation) age of 8.1±0.6 years with mean duration of 3.9±0.2 years. At six months of follow-up, random LH (p=0.048), FSH (p<0.001) and estradiol (p=0.023) concentrations were decreased compared with baseline. Thereafter, random LHs were well suppressed. GRs gradually decreased to prepubertal norm by month 12. Seventeen patients (63%) exhibited pubertal LH concentrations at least once during treatment visits. Furthermore, 43 of a total 116 (37%) LH measurements were found elevated. However, those patients with elevated random LH did not show signs of pubertal progression. After treatment, mean FAH was greater than predicted adult height (p<0.0001) and target height (p=0.03). At no time points of treatment did random LH, FSH and estradiol correlate with GRs or FAH.Conclusion:Elevated random LH is commonly found in ICPP girls during monthly leuprolide treatment. However, these elevations were not associated with clinical progression of puberty or decreased FAH, suggesting that it is not a reliable method for CPP monitoring. http://www.jcrpe.org/archives/archive-detail/article-preview/elevated-random-luteinizing-hormone-is-an-unreliab/21134 Central precocious pubertyfinal adult heightleuprolide acetatemonitoringpubertal progressionrandom luteinizing hormone
spellingShingle Pattara Wiromrat
Ouyporn Panamonta
Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty
JCRPE
Central precocious puberty
final adult height
leuprolide acetate
monitoring
pubertal progression
random luteinizing hormone
title Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty
title_full Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty
title_fullStr Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty
title_full_unstemmed Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty
title_short Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty
title_sort elevated random luteinizing hormone is an unreliable indicator for pubertal suppression in girls treated with monthly leuprolide for idiopathic central precocious puberty
topic Central precocious puberty
final adult height
leuprolide acetate
monitoring
pubertal progression
random luteinizing hormone
url http://www.jcrpe.org/archives/archive-detail/article-preview/elevated-random-luteinizing-hormone-is-an-unreliab/21134
work_keys_str_mv AT pattarawiromrat elevatedrandomluteinizinghormoneisanunreliableindicatorforpubertalsuppressioningirlstreatedwithmonthlyleuprolideforidiopathiccentralprecociouspuberty
AT ouypornpanamonta elevatedrandomluteinizinghormoneisanunreliableindicatorforpubertalsuppressioningirlstreatedwithmonthlyleuprolideforidiopathiccentralprecociouspuberty